Disease Areas
Top Five Articles on 360Dx Last Week: Blood-Based Testing in Neurology; End of NHS England; More
Last week, readers were most interested in a story about how blood-based testing is making increasing inroads for neurological conditions.
The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.
Samsung Invests $10M in Alzheimer's Dx Firm C2N Diagnostics
St. Louis-based C2N said it will use the funds to scale its clinical laboratory services and Alzheimer's testing capabilities.
Beckman Coulter Life Sciences, T-NeuroDx Collaborate on Early Alzheimer's Diagnostics
The collaboration will combine T-NeuroDx's research in Alzheimer's diagnostics with Beckman Coulter's flow cytometry products.
Published on Monday, the work describes a foundational technology being commercialized by startup VedaBio.
Mar 4, 2025
Biodesix Q4 Revenues up 39 Percent
Feb 28, 2025
Castle Biosciences Q4 Revenues up 31 Percent
Feb 28, 2025
Proteomics International Opens US CLIA Laboratory
Feb 28, 2025